💛 A quick favor, if you've got a second.
We're really happy that you chose to read one of our stories and sincerely hope you'll stick around to read more. We took our paywall down — for now — but that won't last forever, and when the gate goes back up, we'd love for you to already be on the inside.
It's free. So please enter your email here and don't forget to like and follow us on all of your favorite Social Media platforms!
Scientists have identified a protein called SORLA that may function as a significant protective mechanism against the neurotoxic tau tangles characteristic of Alzheimer’s disease. Laboratory studies using mice demonstrated that elevated levels of SORLA correlated with reduced tau accumulation in brain tissue, preserved neuronal architecture, and improved synaptic function between neurons.
Conversely, mice lacking sufficient SORLA experienced substantially greater pathological damage, underscoring the protein’s critical role in neurological defense. The research team’s analysis points to the potential for therapeutic interventions targeting this protective mechanism.
Beyond confirming SORLA’s protective properties, the investigation uncovered a promising pharmaceutical target affecting the activity of glial cells, the supportive brain cells that play crucial roles in neuroinflammation. These findings may inform the development of treatments designed to mitigate Alzheimer’s progression and related cognitive decline.
More Stories
New York Health Officials Sound Alarm Over Rising Measles Cases as School Year Approaches
CareCloud Breach Compromises 3.75 Million Patient Records, Among Largest Healthcare Data Thefts of 2026
Month-Long HEPA Use Linked to Faster Cognitive Processing in Middle-Aged Adults